Coenzyme Q10 [Ubiquinone] Market Overview

Coenzyme Q10 (Ubiquinone) Market was valued at USD 392.42 million in 2021 and is expected to reach USD 515.70 million by the year 2028, at a CAGR of 3.98%.

A coenzyme is referring to an organic molecule that holds together the active sites of certain enzymes to help in the catalysis of a reaction. Additionally, coenzymes can role as intermediate carriers of electrons during these reactions or are transferred between enzymes as functional groups. For instance, while the conversion of pyruvate to acetyl coenzyme A (CoA), various coenzymes including free CoA, lipoic acid (LA), thiamine pyrophosphate (TPP), flavin adenine dinucleotide (FAD), two cellular redox enzymes including oxidized nicotinamide adenine dinucleotide (NAD) and minimized nicotinamide adenine dinucleotide (NADH) are required. Moreover, coenzymes, which are frequently vitamins or derivatives of vitamins, hence act as a crucial role in the regulation of most enzyme activities.

Furthermore, some of the aforementioned coenzymes that are involved in the generation of the energy molecule adenosine triphosphate (ATP), various other coenzymes are regarded to be fundamental to the existence of all living cells. Additionally, rising consumer disposal income on account of economic growth in several developing countries helps to the growth of the market. With essential benefits of the merchandise in healthcare usage to market treat cancer, heart health and Huntington's disease have also led towards market growth. The coenzyme was conventionally applied within the treatment of cardiovascular ailments and cognitive illnesses, also as an efficient component in treating periodontal diseases which significantly accelerate the market for the coenzyme Q10 (Ubiquinone) market.

COVID-19 Impact Analysis on Coenzyme Q10 (Ubiquinone) Market

The report covers the Impact of Coronavirus COVID-19: Since the COVID-19 pandemic in December 2019, the disease has spread to almost every country over the world with the World Health Organization announcing it as a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will remarkably influence the Gourmet Salts market in 2020. The COVID-19 pandemic has brought effects on many aspects, such as flight cancellations, travel restrictions, and quarantines, restaurants, and hotels closed, all indoor/outdoor events restricted, around forty countries state of emergency declared, huge slowing of the supply chain, stock market volatility, dropping business confidence, increasing panic among the population, and uncertainty about future.

Market Dynamics And Factors

Drivers:

Coenzyme Q10 is primarily used in pharmaceuticals, nutraceuticals, and the cosmetics industry. Coenzyme Q10 enjoys strong importance in the cosmetic industry, due to its antioxidant characteristics. It is the basic unit that is accountable for 95% of energy generation inside cells, and also acts as a decisive role in treating numerous diseases, such as CVD, secondary diabetes, lungs and kidney problems, and infertility. Therefore, the growing demand for coenzymes is expected to continue during the forecast period.

People who are conscious about health are making use of supplements in the form of capsules, pills, and powders. Coenzymes are basic supplements that are naturally created inside the body. When the level of coenzymes in Q10 declined, it creates significant problems. Therefore, it helps to increased utilization and is anticipated to have a high demand for coenzyme Q10 in the projected period.

Rising demand for healthy food by consumers is another factor that leads to the growth of the coenzyme Q10 market. People in America and Japan are aware of the intake of healthy foods, which will create a massive demand for products that contain coenzyme Q10 in the food market.

Furthermore, its application as a superior antioxidant has accelerated its adoption in various therapeutic applications that focus on reducing the occurrence of several metabolic disorders including diabetes, cancer, and cardiovascular disorders. Additionally, utilization of coenzyme Q10 supplements have encouraged positive outcomes, especially in patients on statin medications. This factor is expected to be the driving force for the growth of the global market for coenzyme Q10 during the future period.

Restraints:

CoQ10 is sold only as a dietary supplement, hampering its potential utilization in the medical industry. Furthermore, strict government & federal regulations associated with drug users are expected to restraint growth of the coenzyme Q10 (Ubiquinone) market during the forecast period.

Opportunities:

Growing awareness related to benefits in eye care and cognitive disease treatment is anticipated to create lucrative opportunities in the upcoming years.

Market Segmentation

Global Coenzyme Q10 [Ubiquinone] Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End-user/application segment analysis and Major key players analysis mentioned as below;

Segmentation Analysis of Coenzyme Q10 [Ubiquinone] Market:

Based on Application, the dietary supplements segment accounted for the largest share. Coenzyme Q10 volume was estimated at around 1,000 tons in 2015. The segment growth is probably to be driven by advantageous product properties that include antioxidant and energy generation properties. There is a massive demand for dietary supplements as well as in the pharmaceutical industry, the health drink producers are also coming up with the new health drink which contains CoQ10.

Regional Insights

North America region dominates coenzyme Q10 (Ubiquinone) market. In North America, there has been a growth in the utilization of coenzymes owing to high incidences of diseases, such as high blood pressure, high cholesterol (especially when taking statin drugs), coronary heart diseases, atherosclerosis, heart arrhythmia diseases, and congestive heart failures. Coenzymes help protect the heart and blood vessels from the damaging effects of oxidative stress. North America is probably to create prolific demand for the coenzyme Q10 (Ubiquinone) market over the forecast period.

Asia Pacific region has emerged as the fastest-growing market for coenzymes. Switching consumer lifestyles, coupled with rising health concerns in developing countries such as India and Japan are anticipated to drive segment growth. The development of small-scale producers along with growing cosmetics demand in India and China would be a positive sign for regional industry growth. Beneficial regulatory guidelines along with a positive application outlook in personal care industry demand would hasten the coenzyme Q10 (Ubiquinone) market demand.

In Europe, ~1 million people are influenced by Parkinson's disease, which has increased the economic burden associated with Parkinson's disease (PD) treatment in the region. According to the Spanish Healthcare System, the early stages of PD require costly treatment, which makes it difficult for middle-class people to bear the growing healthcare costs. Nevertheless, with arising consciousness regarding the benefits of coenzyme Q10, its demand for treating the disease is anticipated to rise among European countries, consequently helping the growth of the coenzyme Q10 market.

North Africa and countries in the Middle East are facing health problems similar to those in western countries. Of these health problems, CVD (cardiovascular diseases) is the high cause of death in these regions. The Middle East and Africa observed ~16% rise in cardiovascular disease rate in 2017. This is anticipated to grow the utilization of coenzyme Q10 in the region over the forecast period. Additionally, another factor helping the growth of the coenzyme Q10 market in the MEA region is the preference for anti-aging creams, according to a UN report.

Players Covered in Coenzyme Q10 [Ubiquinone] Market are:

• Kingdomway
• Kaneka
• Space Biology
• NHU
• Pharma Essentia
• Yuxi Jiankun
• Haotian
• ZMC and Other Major Players.

Key Industry Developments

• In January 2021, a Japanese company, Kaneka Corporation introduced "Watashi no Chikana (My Energy) Q10 Yoghurt". The product provides consumers with a convenient option to accomplish the dietary intake of the active form of CoQ10.
• In July 2018, Xiamen Kingdomway Group Co. introduced its new CoQ10/Magnesium for sports nutrition enthusiasts. These products are naturally generated and are high easier on the digestive tract which may enhance the company's market shares.
• In November 2017, Kaneka Corporation collaborated with Shenzhou Biology and Technology Co., Ltd. They desired to creates arrangements for the provider of Shenzhou's Q10 in North America. This agreement will boost the company's share of oxidized coenzyme Q10 in North America and extend Ubiquinol in China. This decision will help improve coQ10's reach in new locations as Shenzhou will distribute Kaneka's Ubiquinol products in China.
• In June 2016, Xiamen Kingdomway Group Co. purchased Doctor's Best. This decision will promote the application of coenzyme Q10. This is due to Kingdomway is engaged in the manufacturing CoQ10 and Doctor's Best is a leading internet seller.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Application

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  3.5.1 Drivers
  3.5.2 Restraints
  3.5.3 Opportunities
  3.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 4: Coenzyme Q10 [Ubiquinone] Market by Type
 4.1 Coenzyme Q10 [Ubiquinone] Market Overview Snapshot and Growth Engine
 4.2 Coenzyme Q10 [Ubiquinone] Market Overview
 4.3 Chemical Synthesis
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size (2016-2028F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Chemical Synthesis: Grographic Segmentation
 4.4 Microbial Fermentation
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size (2016-2028F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Microbial Fermentation: Grographic Segmentation

Chapter 5: Coenzyme Q10 [Ubiquinone] Market by Application
 5.1 Coenzyme Q10 [Ubiquinone] Market Overview Snapshot and Growth Engine
 5.2 Coenzyme Q10 [Ubiquinone] Market Overview
 5.3 Food
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Food: Grographic Segmentation
 5.4 Medicine
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Medicine: Grographic Segmentation
 5.5 Cosmetics
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Cosmetics: Grographic Segmentation

Chapter 6: Company Profiles and Competitive Analysis
 6.1 Competitive Landscape
  6.1.1 Competitive Positioning
  6.1.2 Coenzyme Q10 [Ubiquinone] Sales and Market Share By Players
  6.1.3 Industry BCG Matrix
  6.1.4 Ansoff Matrix
  6.1.5 Coenzyme Q10 [Ubiquinone] Industry Concentration Ratio (CR5 and HHI)
  6.1.6 Top 5 Coenzyme Q10 [Ubiquinone] Players Market Share
  6.1.7 Mergers and Acquisitions
  6.1.8 Business Strategies By Top Players
 6.2 KINGDOMWAY
  6.2.1 Company Overview
  6.2.2 Key Executives
  6.2.3 Company Snapshot
  6.2.4 Operating Business Segments
  6.2.5 Product Portfolio
  6.2.6 Business Performance
  6.2.7 Key Strategic Moves and Recent Developments
  6.2.8 SWOT Analysis
 6.3 KANEKA
 6.4 SPACE BIOLOGY
 6.5 NHU
 6.6 PHARMA ESSENTIA
 6.7 YUXI JIANKUN
 6.8 HAOTIAN
 6.9 ZMC

Chapter 7: Global Coenzyme Q10 [Ubiquinone] Market Analysis, Insights and Forecast, 2016-2028
 7.1 Market Overview
 7.2 Historic and Forecasted Market Size By Type
  7.2.1 Chemical Synthesis
  7.2.2 Microbial Fermentation
 7.3 Historic and Forecasted Market Size By Application
  7.3.1 Food
  7.3.2 Medicine
  7.3.3 Cosmetics

Chapter 8: North America Coenzyme Q10 [Ubiquinone] Market Analysis, Insights and Forecast, 2016-2028
 8.1 Key Market Trends, Growth Factors and Opportunities
 8.2 Impact of Covid-19
 8.3 Key Players
 8.4 Key Market Trends, Growth Factors and Opportunities
 8.4 Historic and Forecasted Market Size By Type
  8.4.1 Chemical Synthesis
  8.4.2 Microbial Fermentation
 8.5 Historic and Forecasted Market Size By Application
  8.5.1 Food
  8.5.2 Medicine
  8.5.3 Cosmetics
 8.6 Historic and Forecast Market Size by Country
  8.6.1 U.S.
  8.6.2 Canada
  8.6.3 Mexico

Chapter 9: Europe Coenzyme Q10 [Ubiquinone] Market Analysis, Insights and Forecast, 2016-2028
 9.1 Key Market Trends, Growth Factors and Opportunities
 9.2 Impact of Covid-19
 9.3 Key Players
 9.4 Key Market Trends, Growth Factors and Opportunities
 9.4 Historic and Forecasted Market Size By Type
  9.4.1 Chemical Synthesis
  9.4.2 Microbial Fermentation
 9.5 Historic and Forecasted Market Size By Application
  9.5.1 Food
  9.5.2 Medicine
  9.5.3 Cosmetics
 9.6 Historic and Forecast Market Size by Country
  9.6.1 Germany
  9.6.2 U.K.
  9.6.3 France
  9.6.4 Italy
  9.6.5 Russia
  9.6.6 Spain

Chapter 10: Asia-Pacific Coenzyme Q10 [Ubiquinone] Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Type
  10.4.1 Chemical Synthesis
  10.4.2 Microbial Fermentation
 10.5 Historic and Forecasted Market Size By Application
  10.5.1 Food
  10.5.2 Medicine
  10.5.3 Cosmetics
 10.6 Historic and Forecast Market Size by Country
  10.6.1 China
  10.6.2 India
  10.6.3 Japan
  10.6.4 Southeast Asia

Chapter 11: South America Coenzyme Q10 [Ubiquinone] Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 Chemical Synthesis
  11.4.2 Microbial Fermentation
 11.5 Historic and Forecasted Market Size By Application
  11.5.1 Food
  11.5.2 Medicine
  11.5.3 Cosmetics
 11.6 Historic and Forecast Market Size by Country
  11.6.1 Brazil
  11.6.2 Argentina

Chapter 12: Middle East & Africa Coenzyme Q10 [Ubiquinone] Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 Chemical Synthesis
  12.4.2 Microbial Fermentation
 12.5 Historic and Forecasted Market Size By Application
  12.5.1 Food
  12.5.2 Medicine
  12.5.3 Cosmetics
 12.6 Historic and Forecast Market Size by Country
  12.6.1 Saudi Arabia
  12.6.2 South Africa

Chapter 13 Investment Analysis

Chapter 14 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. COENZYME Q10 [UBIQUINONE] MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. COENZYME Q10 [UBIQUINONE] MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. COENZYME Q10 [UBIQUINONE] MARKET COMPETITIVE RIVALRY
TABLE 005. COENZYME Q10 [UBIQUINONE] MARKET THREAT OF NEW ENTRANTS
TABLE 006. COENZYME Q10 [UBIQUINONE] MARKET THREAT OF SUBSTITUTES
TABLE 007. COENZYME Q10 [UBIQUINONE] MARKET BY TYPE
TABLE 008. CHEMICAL SYNTHESIS MARKET OVERVIEW (2016-2028)
TABLE 009. MICROBIAL FERMENTATION MARKET OVERVIEW (2016-2028)
TABLE 010. COENZYME Q10 [UBIQUINONE] MARKET BY APPLICATION
TABLE 011. FOOD MARKET OVERVIEW (2016-2028)
TABLE 012. MEDICINE MARKET OVERVIEW (2016-2028)
TABLE 013. COSMETICS MARKET OVERVIEW (2016-2028)
TABLE 014. NORTH AMERICA COENZYME Q10 [UBIQUINONE] MARKET, BY TYPE (2016-2028)
TABLE 015. NORTH AMERICA COENZYME Q10 [UBIQUINONE] MARKET, BY APPLICATION (2016-2028)
TABLE 016. N COENZYME Q10 [UBIQUINONE] MARKET, BY COUNTRY (2016-2028)
TABLE 017. EUROPE COENZYME Q10 [UBIQUINONE] MARKET, BY TYPE (2016-2028)
TABLE 018. EUROPE COENZYME Q10 [UBIQUINONE] MARKET, BY APPLICATION (2016-2028)
TABLE 019. COENZYME Q10 [UBIQUINONE] MARKET, BY COUNTRY (2016-2028)
TABLE 020. ASIA PACIFIC COENZYME Q10 [UBIQUINONE] MARKET, BY TYPE (2016-2028)
TABLE 021. ASIA PACIFIC COENZYME Q10 [UBIQUINONE] MARKET, BY APPLICATION (2016-2028)
TABLE 022. COENZYME Q10 [UBIQUINONE] MARKET, BY COUNTRY (2016-2028)
TABLE 023. MIDDLE EAST & AFRICA COENZYME Q10 [UBIQUINONE] MARKET, BY TYPE (2016-2028)
TABLE 024. MIDDLE EAST & AFRICA COENZYME Q10 [UBIQUINONE] MARKET, BY APPLICATION (2016-2028)
TABLE 025. COENZYME Q10 [UBIQUINONE] MARKET, BY COUNTRY (2016-2028)
TABLE 026. SOUTH AMERICA COENZYME Q10 [UBIQUINONE] MARKET, BY TYPE (2016-2028)
TABLE 027. SOUTH AMERICA COENZYME Q10 [UBIQUINONE] MARKET, BY APPLICATION (2016-2028)
TABLE 028. COENZYME Q10 [UBIQUINONE] MARKET, BY COUNTRY (2016-2028)
TABLE 029. KINGDOMWAY: SNAPSHOT
TABLE 030. KINGDOMWAY: BUSINESS PERFORMANCE
TABLE 031. KINGDOMWAY: PRODUCT PORTFOLIO
TABLE 032. KINGDOMWAY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 032. KANEKA: SNAPSHOT
TABLE 033. KANEKA: BUSINESS PERFORMANCE
TABLE 034. KANEKA: PRODUCT PORTFOLIO
TABLE 035. KANEKA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 035. SPACE BIOLOGY: SNAPSHOT
TABLE 036. SPACE BIOLOGY: BUSINESS PERFORMANCE
TABLE 037. SPACE BIOLOGY: PRODUCT PORTFOLIO
TABLE 038. SPACE BIOLOGY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 038. NHU: SNAPSHOT
TABLE 039. NHU: BUSINESS PERFORMANCE
TABLE 040. NHU: PRODUCT PORTFOLIO
TABLE 041. NHU: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 041. PHARMA ESSENTIA: SNAPSHOT
TABLE 042. PHARMA ESSENTIA: BUSINESS PERFORMANCE
TABLE 043. PHARMA ESSENTIA: PRODUCT PORTFOLIO
TABLE 044. PHARMA ESSENTIA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 044. YUXI JIANKUN: SNAPSHOT
TABLE 045. YUXI JIANKUN: BUSINESS PERFORMANCE
TABLE 046. YUXI JIANKUN: PRODUCT PORTFOLIO
TABLE 047. YUXI JIANKUN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 047. HAOTIAN: SNAPSHOT
TABLE 048. HAOTIAN: BUSINESS PERFORMANCE
TABLE 049. HAOTIAN: PRODUCT PORTFOLIO
TABLE 050. HAOTIAN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. ZMC: SNAPSHOT
TABLE 051. ZMC: BUSINESS PERFORMANCE
TABLE 052. ZMC: PRODUCT PORTFOLIO
TABLE 053. ZMC: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. COENZYME Q10 [UBIQUINONE] MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. COENZYME Q10 [UBIQUINONE] MARKET OVERVIEW BY TYPE
FIGURE 012. CHEMICAL SYNTHESIS MARKET OVERVIEW (2016-2028)
FIGURE 013. MICROBIAL FERMENTATION MARKET OVERVIEW (2016-2028)
FIGURE 014. COENZYME Q10 [UBIQUINONE] MARKET OVERVIEW BY APPLICATION
FIGURE 015. FOOD MARKET OVERVIEW (2016-2028)
FIGURE 016. MEDICINE MARKET OVERVIEW (2016-2028)
FIGURE 017. COSMETICS MARKET OVERVIEW (2016-2028)
FIGURE 018. NORTH AMERICA COENZYME Q10 [UBIQUINONE] MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 019. EUROPE COENZYME Q10 [UBIQUINONE] MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 020. ASIA PACIFIC COENZYME Q10 [UBIQUINONE] MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 021. MIDDLE EAST & AFRICA COENZYME Q10 [UBIQUINONE] MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. SOUTH AMERICA COENZYME Q10 [UBIQUINONE] MARKET OVERVIEW BY COUNTRY (2016-2028)